Strategies to detect and manage latent tuberculosis infection among household contacts of pulmonary TB patients in high TB burden countries - a systematic review and meta-analysis.

TB preventive therapy diagnosis high TB burden settings household contacts isoniazid preventive therapy latent TB infection screening treatment tuberculosis

Journal

Tropical medicine & international health : TM & IH
ISSN: 1365-3156
Titre abrégé: Trop Med Int Health
Pays: England
ID NLM: 9610576

Informations de publication

Date de publication:
10 2022
Historique:
pubmed: 6 8 2022
medline: 5 10 2022
entrez: 5 8 2022
Statut: ppublish

Résumé

To summarise latent tuberculosis infection (LTBI) management strategies among household contacts of bacteriologically confirmed pulmonary tuberculosis (TB) patients in high-TB burden countries. PubMed/MEDLINE (NCBI) and Scopus were searched (January 2006 to December 2021) for studies reporting primary data on LTBI management. Study selection, data management and data synthesis were protocol-driven (PROSPERO-CRD42021208715). Primary outcomes were the proportions of LTBI, initiating and completing tuberculosis preventive treatment (TPT). Reported factors influencing the LTBI care cascade were qualitatively synthesised. From 3694 unique records retrieved, 58 studies from 23 countries were included. Most identified contacts were screened (median 99%, interquartile range [IQR] 82%-100%; 46 studies). Random-effects meta-analysis yielded pooled proportions for: LTBI 41% (95% confidence interval [CI] 33%-49%; 21,566 tested contacts); TPT initiation 91% (95% CI 79%-97%; 129,573 eligible contacts, 34 studies); TPT completion 65% (95% CI 54%-74%; 108,679 TPT-initiated contacts, 28 studies). Heterogeneity was significant (I The proportions of household contacts screened, detected with LTBI and initiated on TPT, though variable was high, but the proportions completing TPT were lower indicating current strategies used for LTBI management in high TB burden countries are not sufficient.

Identifiants

pubmed: 35927930
doi: 10.1111/tmi.13808
pmc: PMC9825928
doi:

Types de publication

Journal Article Meta-Analysis Review Systematic Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

842-863

Informations de copyright

© 2022 The Authors Tropical Medicine & International Health Published by John Wiley & Sons Ltd.

Références

Int J Infect Dis. 2020 Apr;93:277-283
pubmed: 32081776
Lancet Infect Dis. 2016 Nov;16(11):1269-1278
pubmed: 27522233
BMC Infect Dis. 2017 Apr 11;17(1):259
pubmed: 28399800
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Trop Med Int Health. 2021 Dec;26(12):1645-1651
pubmed: 34654061
Emerg Infect Dis. 2006 Sep;12(9):1383-8
pubmed: 17073087
PLoS One. 2011;6(10):e26787
pubmed: 22066009
Int J Microbiol. 2020 Sep 29;2020:8834806
pubmed: 33061981
PLoS One. 2017 Jan 6;12(1):e0169539
pubmed: 28060926
PLoS Med. 2016 Oct 25;13(10):e1002152
pubmed: 27780211
Int J Mycobacteriol. 2017 Jan-Mar;6(1):27-33
pubmed: 28317801
Int J Tuberc Lung Dis. 2018 Oct 1;22(10):1179-1187
pubmed: 30236186
PLoS One. 2011;6(7):e22500
pubmed: 21799875
BMC Res Notes. 2012 Jan 06;5:7
pubmed: 22221424
PLoS One. 2017 Aug 1;12(8):e0182185
pubmed: 28763500
Int J Tuberc Lung Dis. 2012 Dec;16(12):1594-9
pubmed: 23131256
Int J Tuberc Lung Dis. 2017 Aug 1;21(8):862-868
pubmed: 28786793
Int J Tuberc Lung Dis. 2016 Aug;20(8):1078-83
pubmed: 27393543
Open Forum Infect Dis. 2020 Nov 11;8(1):ofaa520
pubmed: 33511219
J Public Health Afr. 2019 Jun 12;10(1):827
pubmed: 31285812
Public Health Action. 2016 Dec 21;6(4):226-231
pubmed: 28123958
Indian J Tuberc. 2020 Oct;67(4):459-465
pubmed: 33077044
BMJ Open. 2021 Feb 23;11(2):e040993
pubmed: 33622944
Int J Tuberc Lung Dis. 2020 Apr 1;24(4):452-460
pubmed: 32317071
JAMA Netw Open. 2020 Jan 3;3(1):e1919325
pubmed: 31922554
Int J Tuberc Lung Dis. 2009 Dec;13(12):1507-12
pubmed: 19919768
BMC Infect Dis. 2021 Aug 13;21(1):815
pubmed: 34388985
Lancet Public Health. 2021 May;6(5):e272-e282
pubmed: 33765453
Trop Med Int Health. 2022 Oct;27(10):842-863
pubmed: 35927930
Int J Tuberc Lung Dis. 2019 Sep 1;23(9):989-995
pubmed: 31615605
PLoS One. 2020 Oct 9;15(10):e0240031
pubmed: 33035249
Int J Tuberc Lung Dis. 2017 Sep 1;21(9):1002-1007
pubmed: 28826449
PLoS One. 2016 Jun 10;11(6):e0155348
pubmed: 27285720
Trop Med Infect Dis. 2021 Nov 30;6(4):
pubmed: 34941662
Int J Tuberc Lung Dis. 2013 Feb;17(2):163-8
pubmed: 23317950
PLoS One. 2020 Jul 29;15(7):e0236743
pubmed: 32726367
Int J Tuberc Lung Dis. 2011 Dec;15(12):1637-43
pubmed: 22118171
BMC Infect Dis. 2017 Sep 16;17(1):623
pubmed: 28915796
Am J Trop Med Hyg. 2009 Mar;80(3):351-8
pubmed: 19270281
PLoS One. 2019 Feb 11;14(2):e0211934
pubmed: 30742660
Int J Tuberc Lung Dis. 2020 Jan 1;24(1):100-109
pubmed: 32005312
Int J Tuberc Lung Dis. 2009 Jun;13(6):719-25
pubmed: 19460247
Eur Respir J. 2021 Dec 9;58(6):
pubmed: 34016621
Tuberc Res Treat. 2020 Jun 05;2020:6734675
pubmed: 32566291
J Trop Pediatr. 2017 Aug 1;63(4):274-285
pubmed: 28082666
Paediatr Int Child Health. 2021 Nov;41(4):237-246
pubmed: 34533111
PLoS One. 2013 Dec 10;8(12):e80803
pubmed: 24339884
BMC Infect Dis. 2009 Jun 17;9:96
pubmed: 19534769
Indian J Tuberc. 2022 Jan;69(1):100-103
pubmed: 35074140
PLoS One. 2011;6(11):e26452
pubmed: 22069451
S Afr Med J. 2018 Feb 27;108(3):217-223
pubmed: 30004366
Southeast Asian J Trop Med Public Health. 2015 May;46(3):486-95
pubmed: 26521523
PLoS One. 2016 May 19;11(5):e0155525
pubmed: 27196627
Int J Tuberc Lung Dis. 2016 Apr;20(4):479-86
pubmed: 26970157
Am J Epidemiol. 2018 Jul 1;187(7):1477-1489
pubmed: 29304247
Int J Tuberc Lung Dis. 2016 Aug;20(8):1055-9
pubmed: 27393539
Indian J Pediatr. 2013 Apr;80(4):276-80
pubmed: 22688652
Bull World Health Organ. 2018 Jun 01;96(6):386-392
pubmed: 29904221
PLoS One. 2018 Aug 1;13(8):e0199360
pubmed: 30067752
Pan Afr Med J. 2020 Sep 25;37:87
pubmed: 33244350
Eur J Public Health. 2013 Dec;23(6):1064-9
pubmed: 23867560
Trans R Soc Trop Med Hyg. 2017 Feb 1;111(2):55-61
pubmed: 28407146
Pediatr Infect Dis J. 2021 Aug 1;40(8):763-770
pubmed: 34050092
Int J Tuberc Lung Dis. 2014 Aug;18(8):919-24
pubmed: 25199005
Eur Respir J. 2013 Jan;41(1):140-56
pubmed: 22936710
PLoS One. 2020 Mar 17;15(3):e0230376
pubmed: 32182274
Arch Dis Child. 2006 Sep;91(9):762-5
pubmed: 16737993

Auteurs

Karuna Devi Sagili (KD)

International Union Against Tuberculosis and Lung Disease, South East Asia Office, New Delhi, India.

Malaisamy Muniyandi (M)

Indian Council of Medical Research (ICMR), National Institution for Research in Tuberculosis, Chennai, India.

Kalpita Shringarpure (K)

Department of Community Medicine, Medical College Baroda, Baroda, India.

Kavita Singh (K)

International Union Against Tuberculosis and Lung Disease, South East Asia Office, New Delhi, India.

Richard Kirubakaran (R)

Clinical Epidemiology Unit, Christian Medical Centre, Vellore, India.

Raghuram Rao (R)

National TB Elimination Program, Central TB Division, Ministry of Health, New Delhi, India.

Jamhoih Tonsing (J)

Technical Advice and Partnerships Department, The Global Fund, Geneva, Switzerland.

Kuldeep Singh Sachdeva (KS)

International Union Against Tuberculosis and Lung Disease, South East Asia Office, New Delhi, India.

Prathap Tharyan (P)

Clinical Epidemiology Unit, Christian Medical Centre, Vellore, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH